Pycnogenol for Eye Health: See The Difference

Screen Time, Aging Eyes, and the Role of Pycnogenol® in Retinal Health

In today’s digital world, our eyes are working harder than ever before. According to the American Academy of Ophthalmology, the average office worker spends around 1,700 hours per year in front of a computer screen. Add smartphones, tablets, and streaming devices to the mix, and daily screen exposure climbs even higher.

Unsurprisingly, long hours of screen time can result in eye strain, irritation, dryness, and fatigue. During the COVID-19 lockdowns, these challenges became even more evident. A survey by the College of Optometrists found that 22% of respondents noticed a deterioration in their vision during lockdown—while fewer people attended routine eye examinations.

But digital strain is only part of the story. Natural aging and chronic health conditions also significantly affect visual health.

The Aging Eye and Oxidative Stress

As we age, our eyes undergo structural and functional changes. These may include:

• Age-related macular degeneration (AMD)

• Corneal and retinal alterations

• Declining visual acuity

• Lacrimal system dysfunction (affecting tear production)

The progression of these changes depends on hereditary factors, lifestyle, and diet. A key underlying driver is oxidative stress.

The retina has the highest metabolic rate of any tissue in the body, making it particularly vulnerable to oxidative damage. In addition to intense metabolic activity, eye tissue is constantly exposed to UV light, which generates reactive oxygen species (ROS). Over time, cumulative oxidative damage can impair retinal cells and vascular structures.

Metabolic diseases such as diabetes further amplify oxidative stress, increasing the risk of serious retinal complications.

Pycnogenol® and Diabetic Retinopathy

One of the most serious ocular complications of diabetes is diabetic retinopathy—a microvascular condition caused by prolonged high blood sugar and high blood pressure. These factors increase oxidative stress and damage the retina, the light-sensitive inner layer of the eye.

In its early stages, diabetic retinopathy may progress without symptoms. If left untreated, however, it can lead to:

• Capillary leakage

• Retinal dysfunction

• Macular edema

• Neovascularization

• In severe cases, blindness

Research suggests that Pycnogenol®, a standardized French maritime pine bark extract, may support retinal health in diabetic patients.

In placebo-controlled, double-blind, randomized studies, Pycnogenol® supplementation demonstrated:

• Reduced vascular permeability (16% improvement in the left eye and 23% in the right eye)

• Significant improvements in ophthalmoscopy scores (9% and 17%)

• Increased visual acuity (5.7% and 7%)

In contrast, patients receiving placebo experienced continued progression of retinopathy and reduced visual acuity as measured by the Snellen chart.

Another clinical study found that after three months of supplementation, retinal edema improved by:

• 30% in mild cases

• 35% in moderate cases

These findings suggest that Pycnogenol® may help stabilize leaky capillaries, improve microcirculation, and support endothelial function—key mechanisms in preserving retinal integrity.

Protection of Retinal Capillaries in Retinal Vein Thrombosis

Retinal vein thrombosis (RVT) is the second most common retinal vascular disease after diabetic retinopathy. Major risk factors include:

• Hypertension

• Diabetes mellitus

• Dyslipidemia

• High BMI

• Smoking

Patients may experience blurred vision or sudden, painless vision loss. Macular edema is the most frequent cause of visual impairment in RVT.

Clinical studies investigating Pycnogenol® supplementation found:

• Recurrence rates of RVT were 3.6% in the Pycnogenol® group versus 17.4% in controls

• Edema was reduced by 55% compared to baseline

• In a 12-month study of 307 patients, recurrence was reduced by 19.4% compared to controls

Outcomes were significantly better than in patients treated with antiplatelet agents such as aspirin, ticlopidine, or sulodexide.

Pycnogenol® has demonstrated mild but meaningful antithrombotic and antiplatelet activity, along with improved microcirculation in chronic venous insufficiency. These vascular benefits likely contribute to its positive effects in retinal vein thrombosis.

Antioxidant Protection for the Retina

Oxidative stress and inflammation are central contributors to retinopathies and age-related macular degeneration. Given the retina’s high metabolic demand, antioxidant protection is crucial.

In comparative laboratory studies, Pycnogenol® demonstrated stronger protection against retinal lipid peroxidation than vitamin C, vitamin E, CoQ10, lipoic acid, and grape seed extract.

Key findings include:

• 61% inhibition of lipid peroxidation at 50 ng/ml

• 93% inhibition at 250 ng/ml

In combination with lutein, Pycnogenol® showed synergistic protective effects. While lutein alone had limited impact in this model, the combination improved lipid peroxidation reduction from 29% to 47%.

These results highlight the potential of combining targeted antioxidants for enhanced retinal protection.

Supporting Eye Health in a Digital and Aging World

From excessive screen exposure to age-related changes and chronic metabolic disease, our eyes face multiple stressors. The retina, in particular, is highly susceptible to oxidative and vascular damage.

Evidence suggests that Pycnogenol® French maritime pine bark extract may:

• Support capillary integrity

• Improve microcirculation

• Reduce retinal edema

• Enhance visual acuity

• Provide potent antioxidant protection

While regular eye examinations and healthy lifestyle choices remain essential, targeted nutritional strategies may offer additional support for long-term retinal health.

Pycnogenol® French maritime pine bark extract is a safe, natural and evidence-based solution to support eye health. Pycnogenol® was shown to have beneficial effects in patients with diabetic retinopathy, retinal vein thrombosis and showed generally potent antioxidant effects on the retina.